Use of Palliative Endocrine Therapy in Patients with Hormone Receptor-Positive Distant Metastatic Breast Cancer: How Often, How Effective, How Long?

Publisher： Karger

E-ISSN： 1423-0232|90|1|1-9

ISSN： 0030-2414

Source： Oncology, Vol.90, Iss.1, 2016-0, pp. : 1-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimizing Quality of Life in Patients with Hormone Receptor-Positive Metastatic Breast Cancer: Treatment Options and Considerations

By  

Oncology, Vol. 93, Iss. 3, 2017-06 ,pp. : 143-156

Karger

Access to resources Recommend Favorite

Immunohistochemical Detection of Breast Cancer Stem Cells in Hormone Receptor-Positive Breast Cancer and Their Role in Response to Endocrine Therapy and Clinical Outcome

By  

Oncology, Vol. 82, Iss. 3, 2012-03 ,pp. : 168-174

Karger

Access to resources Recommend Favorite

Clinical Utility of Neoadjuvant Endocrine Therapy for Hormone Receptor Positive Breast Cancer

By  

Reviews on Recent Clinical Trials, Vol. 12, Iss. 2, 2017-05 ,pp. : 67-72

Bentham Science Publishers

Access to resources Recommend Favorite

Critical Appraisal of Primary Systemic Endocrine Therapy in Receptor-Positive Postmenopausal Breast Cancer: An Update

By  

Oncology Research and Treatment, Vol. 29, Iss. 5, 2006-05 ,pp. : 210-217

Karger

Access to resources Recommend Favorite

A Case of Disease Improvement after Treatment with Everolimus plus Exemestane in a Patient with Hormone Receptor-Positive Metastatic Breast Cancer with Bone Metastases

By  

Case Reports in Oncology, Vol. 8, Iss. 1, 2015-02 ,pp. : 101-105

Karger

Access to resources Recommend Favorite